{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:31:07Z","timestamp":1792373467894,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2013.12.026","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T10:45:15Z","timestamp":1387795515000},"page":"4376-4385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["The delicate balance in genetically engineering live vaccines"],"prefix":"10.1016","volume":"32","author":[{"given":"James E.","family":"Galen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"Roy","family":"Curtiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.12.026_bib0005","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2013.12.026_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.01904.x","article-title":"So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars typhimurium and typhi","volume":"305","author":"Sabbagh","year":"2010","journal-title":"FEMS Microbiol Lett"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.026_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrmicro1788","article-title":"Salmonellae interplay with host cells","volume":"6","author":"Haraga","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2013.12.026_bib0020","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1007\/s00018-011-0841-0","article-title":"Salmonella effector proteins and host-cell responses","volume":"68","author":"Srikanth","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2013.12.026_bib0025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1099\/mic.0.058115-0","article-title":"Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors","volume":"158","author":"Figueira","year":"2012","journal-title":"Microbiology"},{"issue":"June (7)","key":"10.1016\/j.vaccine.2013.12.026_bib0030","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1286-4579(01)01411-3","article-title":"Salmonella pathogenicity islands encoding type III secretion systems","volume":"3","author":"Hansen-Wester","year":"2001","journal-title":"Microbes Infect"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.12.026_bib0035","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"issue":"April (20)","key":"10.1016\/j.vaccine.2013.12.026_bib0040","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1016\/j.vaccine.2010.02.017","article-title":"In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7\u00d710(10) colony-forming units","volume":"28","author":"Lyon","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0045","series-title":"New generation vaccines","first-page":"497","article-title":"Attenuated strains of Salmonella enterica serovars Typhi and Paratyphi as live oral vaccines against enteric fever","author":"Levine","year":"2010"},{"issue":"February (15)","key":"10.1016\/j.vaccine.2013.12.026_bib0050","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0264-410X(99)00424-7","article-title":"Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines: effect of formulation on safety and immunogenicity","volume":"18","author":"Dilts","year":"2000","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.026_bib0055","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI112899","article-title":"Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans","volume":"79","author":"Levine","year":"1987","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vaccine.2013.12.026_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0264-410X(95)00173-X","article-title":"Evaluation of a phoP\/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers","volume":"14","author":"Hohmann","year":"1996","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.12.026_bib0065","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/173.6.1408","article-title":"phoP\/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers","volume":"173","author":"Hohmann","year":"1996","journal-title":"J Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.12.026_bib0070","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/IAI.05398-11","article-title":"Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium","volume":"79","author":"Kong","year":"2011","journal-title":"Infect Immun"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2013.12.026_bib0075","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/JB.188.7.2735-2739.2006","article-title":"Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar typhimurium with macrophages and complement","volume":"188","author":"Murray","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0080","article-title":"Structural diversity in Salmonella O antigens and its genetic basis","author":"Liu","year":"2013","journal-title":"FEMS Microbiol Rev"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2013.12.026_bib0085","doi-asserted-by":"crossref","first-page":"15052","DOI":"10.1074\/jbc.M901429200","article-title":"Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin","volume":"284","author":"Resman","year":"2009","journal-title":"J Biol Chem"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2013.12.026_bib0090","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1074\/jbc.M109.075127","article-title":"MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation","volume":"285","author":"Meng","year":"2010","journal-title":"J Biol Chem"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.12.026_bib0095","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1128\/IAI.00123-12","article-title":"Phosphate groups of lipid A are essential for Salmonella enterica serovar typhimurium virulence and affect innate and adaptive immunity","volume":"80","author":"Kong","year":"2012","journal-title":"Infect Immun"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2013.12.026_bib0100","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.vaccine.2011.01.099","article-title":"A live attenuated strain of Yersinia pestis KIM as a vaccine against plague","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2013.12.026_bib0105","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/IAI.01403-12","article-title":"Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A","volume":"81","author":"Sun","year":"2013","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.026_bib0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/IAI.00693-08","article-title":"Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo","volume":"77","author":"Curtiss","year":"2009","journal-title":"Infect Immun"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2013.12.026_bib0115","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1574-6976.2010.00226.x","article-title":"AraC protein, regulation of the l-arabinose operon in Escherichia coli, and the light switch mechanism of AraC action","volume":"34","author":"Schleif","year":"2010","journal-title":"FEMS Microbiol Rev"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2013.12.026_bib0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1073\/pnas.0811697106","article-title":"Evaluation of new generation Salmonella enterica serovar typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA","volume":"106","author":"Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.12.026_bib0125","doi-asserted-by":"crossref","first-page":"e11142","DOI":"10.1371\/journal.pone.0011142","article-title":"Live recombinant Salmonella typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen","volume":"5","author":"Shi","year":"2010","journal-title":"PLoS ONE"},{"issue":"42","key":"10.1016\/j.vaccine.2013.12.026_bib0130","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.vaccine.2013.07.049","article-title":"A phase 1 dose-escalation trial in adults of three recombinant attenuated Salmonella typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA","volume":"31","author":"Frey","year":"2013","journal-title":"Vaccine"},{"issue":"July (5)","key":"10.1016\/j.vaccine.2013.12.026_bib0135","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4161\/viru.24886","article-title":"Attenuating gene expression (AGE) for vaccine development","volume":"4","author":"Pascual","year":"2013","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.vaccine.2013.12.026_bib0140","doi-asserted-by":"crossref","first-page":"e46828","DOI":"10.1371\/journal.pone.0046828","article-title":"Flagella overexpression attenuates Salmonella pathogenesis","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2013.12.026_bib0145","doi-asserted-by":"crossref","first-page":"e36283","DOI":"10.1371\/journal.pone.0036283","article-title":"Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector","volume":"7","author":"Cao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-1119(90)90464-3","article-title":"Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains","volume":"94","author":"Gal\u00e1n","year":"1990","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0155","series-title":"Escherichia coli and Salmonella: cellular and molecular biology","first-page":"458","article-title":"Biosynthesis of the aromatic amino acids","author":"Pittard","year":"1996"},{"issue":"September (7\u20138)","key":"10.1016\/j.vaccine.2013.12.026_bib0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0923-2508(90)90113-5","article-title":"Stabilization of recombinant avirulent vaccine strains in vivo","volume":"141","author":"Curtiss","year":"1990","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.bi.55.070186.000535","article-title":"Single-stranded DNA binding proteins required for DNA replication","volume":"55","author":"Chase","year":"1986","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev.bi.63.070194.002523","article-title":"Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities","volume":"63","author":"Lohman","year":"1994","journal-title":"Annu Rev Biochem"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.026_bib0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/IAI.00916-09","article-title":"A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar typhi live vectors","volume":"78","author":"Galen","year":"2010","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2013.12.026_bib0180","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.4161\/hv.23248","article-title":"Novel methods for expression of foreign antigens in live vector vaccines","volume":"9","author":"Wang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2013.12.026_bib0185","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1128\/IAI.69.12.7493-7500.2001","article-title":"Regulated antigen expression in live recombinant Salmonella enterica serovar typhimurium strongly affects colonization capabilities and specific CD4+-T-cell responses","volume":"69","author":"Bumann","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2013.12.026_bib0190","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0966-842X(01)02096-0","article-title":"Can a \u2018flawless\u2019 live vector vaccine strain be engineered?","volume":"9","author":"Galen","year":"2001","journal-title":"Trends Microbiol"},{"issue":"July (5)","key":"10.1016\/j.vaccine.2013.12.026_bib0195","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/icb.2009.31","article-title":"Salmonella enterica serovar typhi live vector vaccines finally come of age","volume":"87","author":"Galen","year":"2009","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.12.026_bib0200","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1615\/CritRevImmunol.v30.i3.30","article-title":"New technologies in using recombinant attenuated Salmonella vaccine vectors","volume":"30","author":"Curtiss","year":"2010","journal-title":"Crit Rev Immunol"},{"issue":"January (1\u20132)","key":"10.1016\/j.vaccine.2013.12.026_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijmm.2007.07.005","article-title":"Improving live attenuated bacterial carriers for vaccination and therapy","volume":"298","author":"Loessner","year":"2008","journal-title":"Int J Med Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.026_bib0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fmb.11.144","article-title":"Salmonella enterica as a vaccine carrier","volume":"7","author":"Hegazy","year":"2012","journal-title":"Future Microbiol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2013.12.026_bib0215","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1128\/IAI.00444-10","article-title":"Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity","volume":"78","author":"Wang","year":"2010","journal-title":"Infect Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.12.026_bib0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00018-006-6296-z","article-title":"The lactose repressor system: paradigms for regulation, allosteric behavior and protein folding","volume":"64","author":"Wilson","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2013.12.026_bib0225","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1128\/JB.01732-07","article-title":"The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter","volume":"190","author":"Husnain","year":"2008","journal-title":"J Bacteriol"},{"issue":"March (Pt 3)","key":"10.1016\/j.vaccine.2013.12.026_bib0230","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1099\/mic.0.023754-0","article-title":"Salmonella enterica serovar typhimurium HtrA: regulation of expression and role of the chaperone and protease activities during infection","volume":"155","author":"Lewis","year":"2009","journal-title":"Microbiology"},{"issue":"July (2\u20133)","key":"10.1016\/j.vaccine.2013.12.026_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-8244(03)00063-4","article-title":"Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization","volume":"37","author":"Kang","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2013.12.026_bib0240","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/IAI.72.12.7096-7106.2004","article-title":"Adaptation of the endogenous Salmonella enterica serovar typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA","volume":"72","author":"Galen","year":"2004","journal-title":"Infect Immun"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2013.12.026_bib0245","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/596066","article-title":"Mucosal immunization with attenuated Salmonella enterica serovar typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine","volume":"199","author":"Galen","year":"2009","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2013.12.026_bib0250","doi-asserted-by":"crossref","first-page":"e1002966","DOI":"10.1371\/journal.ppat.1002966","article-title":"Immunity to intracellular Salmonella depends on surface-associated antigens","volume":"8","author":"Barat","year":"2012","journal-title":"PLoS Pathog"},{"issue":"July (5376)","key":"10.1016\/j.vaccine.2013.12.026_bib0255","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.281.5376.565","article-title":"Delivery of epitopes by the Salmonella type III secretion system for vaccine development","volume":"281","author":"Russmann","year":"1998","journal-title":"Science"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.12.026_bib0260","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/IAI.06056-11","article-title":"Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens","volume":"80","author":"Hegazy","year":"2012","journal-title":"Infect Immun"},{"issue":"July (27)","key":"10.1016\/j.vaccine.2013.12.026_bib0265","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1073\/pnas.0803801105","article-title":"Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment","volume":"105","author":"Kong","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (5234)","key":"10.1016\/j.vaccine.2013.12.026_bib0270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1126\/science.270.5234.299","article-title":"Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization","volume":"270","author":"Sizemore","year":"1995","journal-title":"Science"},{"issue":"June (8)","key":"10.1016\/j.vaccine.2013.12.026_bib0275","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0264-410X(96)00252-6","article-title":"Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization","volume":"15","author":"Sizemore","year":"1997","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.12.026_bib0280","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JVI.77.9.5209-5217.2003","article-title":"Attenuated Salmonella enterica serovar typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats","volume":"77","author":"Pasetti","year":"2003","journal-title":"J Virol"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2013.12.026_bib0285","doi-asserted-by":"crossref","first-page":"19414","DOI":"10.1073\/pnas.1217554109","article-title":"Turning self-destructing Salmonella into a universal DNA vaccine delivery platform","volume":"109","author":"Kong","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.12.026_bib0290","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1128\/IAI.05278-11","article-title":"Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains","volume":"79","author":"Tennant","year":"2011","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.12.026_bib0295","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/IAI.05484-11","article-title":"Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis","volume":"79","author":"Simon","year":"2011","journal-title":"Infect Immun"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.12.026_bib0300","doi-asserted-by":"crossref","first-page":"e64680","DOI":"10.1371\/journal.pone.0064680","article-title":"Sustained protection in mice immunized with fractional doses of Salmonella enteritidis core and o polysaccharide-flagellin glycoconjugates","volume":"8","author":"Simon","year":"2013","journal-title":"PLoS ONE"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2013.12.026_bib0305","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.vaccine.2010.11.017","article-title":"A novel Salmonella typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer","volume":"29","author":"Vendrell","year":"2011","journal-title":"Vaccine"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2013.12.026_bib0310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/CJI.0b013e3182886d95","article-title":"Therapeutic effects of Salmonella typhi in a mouse model of T-cell lymphoma","volume":"36","author":"Vendrell","year":"2013","journal-title":"J Immunother"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2013.12.026_bib0315","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/ijc.24957","article-title":"Novel cancer vaccine based on genes of Salmonella pathogenicity island 2","volume":"126","author":"Xiong","year":"2010","journal-title":"Int J Cancer"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2013.12.026_bib0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11912-012-0215-2","article-title":"Survivin in solid tumors: rationale for development of inhibitors","volume":"14","author":"Church","year":"2012","journal-title":"Curr Oncol Rep"},{"issue":"June (30)","key":"10.1016\/j.vaccine.2013.12.026_bib0325","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.vaccine.2009.04.041","article-title":"The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix","volume":"27","author":"Maciag","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.026_bib0330","doi-asserted-by":"crossref","first-page":"542851","DOI":"10.1155\/2012\/542851","article-title":"Lm-LLO-based immunotherapies and HPV-associated disease","volume":"2012","author":"Wallecha","year":"2012","journal-title":"J Oncol"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2013.12.026_bib0335","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.4049\/jimmunol.167.11.6471","volume":"167","author":"Gunn","year":"2001","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301757X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301757X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:08Z","timestamp":1759400528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1301757X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":67,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X1301757X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The delicate balance in genetically engineering live vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}